migraine relief NDC 72288-286

Product information

Brand name (proprietary)

migraine relief

Generic name (nonproprietary)

acetaminophen, aspirin, caffeine

Active ingredients

Acetaminophen — 250 mg/1Aspirin — 250 mg/1Caffeine — 65 mg/1

Dosage form

Tablet, Film coated

Route

Oral

Labeler

Amazon.com Services LLC

Product type

Over-the-counter drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 075794

Marketing start

Sep 11, 2026

Listing expires

Dec 31, 2027

Other FDA classes

Non-Steroidal (Chemical structure)Central Nervous System Stimulation (Physiologic effect)Cyclooxygenase Inhibitors (Mechanism)Decreased Platelet Aggregation (Physiologic effect)Decreased Prostaglandin Production (Physiologic effect)Xanthines (Chemical structure)

Identifiers

Product ID 72288-286_26495ff4-57bc-4e28-b04c-d2da16be4c27SPL ID 26495ff4-57bc-4e28-b04c-d2da16be4c27

Pharmacologic class

Central Nervous System Stimulant; Methylxanthine; Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472288028627 followed by a unit qualifier and the quantity Copy

Package 72288-0286-27. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under ANDA 075794

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

Showing 20 of 27.